| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 4e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 1e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.0009 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |